Status:
COMPLETED
rTMS and Multi-Modality Aphasia Therapy for Post-Stroke Aphasia
Lead Sponsor:
University of Calgary
Conditions:
Stroke
Aphasia, Non-fluent
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Many stroke survivors experience aphasia, a loss or impairment of language affecting the production or understanding of speech. One common type of aphasia is known as non-fluent aphasia. Patients with...
Eligibility Criteria
Inclusion
- Isolated left middle cerebral artery (MCA) stroke more than 6 months ago (chronic)
- Stroke type: Ischemic or hemorrhagic
- Non-fluent aphasia as determined by the Western Aphasia Battery (Fluency \< 5)
- Right-hand dominant prior to stroke
- English is first or primary language
- Ability to follow 3-step commands
Exclusion
- Prior stroke to the right frontal lobe
- Current diagnosis of moderate to severe depression
- Diagnosis of any other psychiatric condition
- History of other neurologic disorders (e.g., epilepsy, brain tumor)
- Contraindication to MRI or TMS (metal in the head or any implanted electrical device)
- Has received intensive speech therapy within the past 6 months (\>8 hours per week)
- Enrolled in another interventional study
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04901156
Start Date
April 1 2018
End Date
January 31 2020
Last Update
September 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Foothills Medical Centre
Calgary, Alberta, Canada, T2N 2T9